News
VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) reports that at its Annual General and Special Meeting ...
VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) reports that at its Annual General and Special Meeting (the “AGSM”) ...
VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) reports that at its Annual General and Special Meeting ...
VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) reports that at its Annual General and Special Meeting ...
MAG Reports AGSM Results Provided by GlobeNewswire Jun 18, 2025, 9:06:46 PM. VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) ...
VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or “MAG Silver”) reports that at its Annual General and Special Meeting (the “AGSM”) ...
VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG” or“MAG Silver”) ...
MAG Reports AGSM Results. MAG Silver Corp. - GlobeNewswire - 39 minutes ago. VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) ...
Detailed results of the total shares voted at the AGSM are set out below. Motions: Nominees: Total Votes Cast: Total Votes For: Total Votes Withheld % For % Withheld: John Armstrong: 76,498,772: ...
Neighbors have been hearing the barks of two dogs left alone inside a house in Verona, Allegheny County, according to the local police chief. Skip to content NOWCAST Pittsburgh's Action News 4 at Noon ...
At the AGSM, a total of 29,212,122 common shares were represented by proxy, representing 77.86% of the Company's outstanding common shares. The final voting results of the meeting are set out below.
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 biotech stocks screaming a buy. On June 17, Roth Capital increased its price target to $116 from $92 while reiterating a Buy rating. The adjustment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results